The Problem: Underuse of Generic Drugs
With up to $2.7 Trillion spent annually on healthcare, you need a clear understanding of cost, quality and utilization to help reduce your costs. A recent study by the NEHI showed a $3 Billion savings opportunity for a given population by converting from brand-label to generic antihypertensives. Solutions like our Enterprise Intelligence will help cut through the clutter and minimize your program inefficiencies.
$3 Billion
Savings from switching to equally effective, generic hypertensives
9 Million
The total active participants currently in Taft Hartley Funds
